Relative in vitro efficacy of the phosph
β
Valerie Autissier; Stephen J.P. Damment; Richard A. Henderson
π
Article
π
2007
π
John Wiley and Sons
π
English
β 194 KB
The high tablet burden and poor compliance associated with phosphate-binding drugs has led to a search for more potent agents. In vitro-binding studies were performed on the recently introduced binder, lanthanum carbonate (LC; Fosrenol), to compare its phosphate-binding affinity with sevelamer hydro